Drug intelligence / Profile preview

mineral oil + white petrolatum

Development stage: Unknown
Lead developer: Radisson
Modality: Small Molecules
Administration: Ophthalmic

Overview

Raditear PM Eye Ointment is an over-the-counter lubricating ophthalmic ointment developed and distributed by Radisson Pharmaceuticals. Formulated specifically for nighttime use, it contains a blend of white petrolatum and mineral oil. The ointment acts as an ocular emollient and lubricant, spreading across the conjunctiva and cornea to form a protective, occlusive barrier. This barrier mimics the lipid layer of the natural tear film, preventing tear evaporation and shielding the ocular surface from dryness and irritation during sleep. It is primarily indicated for the temporary relief of dry eye symptoms, burning, and ocular discomfort.

Brand names: Raditear PM Eye Ointment
Other names: mineral oil and white petrolatum ophthalmic ointmentwhite petrolatum + mineral oil

Beyond the preview

Go deeper on mineral oil + white petrolatum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mineral oil + white petrolatum.